https://researchopenworld.com/the-akt-signaling-pathway-in-skin-cancer-cell-lines-treated-with-rrm-mv-a-short-peptide-analogue-of-the-mt5-protein-of-myxoma-virus/#Taghrid Istivan(MIT University)Cancer Studies and TherapeuticsMarch 25, 201810.31038/cst.2018321Cited by 0SaveCiteExport RISWatch citationsRelated PapersBiological Effects of a De Novo Designed Myxoma Virus Peptide Analogue: Evaluation of Cytotoxicity on Tumor Cells|PLoS ONE|2011|57A bioactive peptide analogue for myxoma virus protein with a targeted cytotoxicity for human skin cancer in vitro|Journal of Biomedical Science|2012|18